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ABSTRACT
We describe a generic design for ratiometric
analysis suitable for determination of copy number
variation (CNV) class of a gene. Following two initial
sequence-specific PCR priming cycles, both ends of
both amplicons (one test and one reference) in a
duplex reaction, are all primed by the same univer-
sal primer (UP). Following each amplification
denaturation step, the UP target and its reverse
complement (UP0) in each strand form a hairpin.
The bases immediately beyond the 30-end of the
UP and 50 of UP0 are chosen such as not to base
pair in the hairpin (otherwise priming is ablated).
This hairpin creates a single constant environment
for priming events and chaperones free 30-ends
of amplicon strands. The resultant ‘amplification
ratio control system’ (ARCS) permits ratiometric
representation of amplicons relative to the original
template into PCR plateau phase. These advan-
tages circumvent the need for real-time PCR for
quantitation. Choice of different %(G+C) content
for the target and reference amplicons allows
liquid phase thermal melt discrimination and
quantitation of amplicons. The design is generic,
simple to set up and economical. Comparisons
with real-time PCR and other techniques are made
and CNV assays demonstrated for haptoglobin
duplicon and ‘chemokine (C-C motif) ligand 3-like
1’ gene.
INTRODUCTION
Many human genes have now been recognized to exhibit
copy number variation (CNV). Conﬁrmation of pheno-
typic associations for single nucleotide polymorphisms
(SNPs) identiﬁed in genome-wide association studies
(GWAS) have generally required single SNP typing for
follow-up replications in 20000–100000 study partici-
pants and a similar situation can be anticipated for
CNVs based on the effect sizes observed to date (1).
However, where there are numerous suitable methods
for (qualitative) SNP assays, there remains a shortfall
for (quantitative) CNV assays. Current methods used
for CNV assays are summarized in Supplementary
Table S1. These include: quantitative multiplex PCR of
short ﬂuorescent fragments (QMPSF) (2); multiplex
ampliﬁable probe hybridization (MAPH) (3); multiplex
ligation-dependent genome ampliﬁcation (MLGA) (4);
multiplex ligation-dependent probe ampliﬁcation
(MLPA) (5); real time PCR (6); and paralog ratio test
(PRT) (7). Real time PCR and PRT are the only
methods of those currently used that offer scope for
large-scale studies in terms of throughput, cost, conveni-
ence, accuracy and precision. Comparison of PRT and
real-time PCR (8) has shown potentially superior per-
formance of PRT; however, PRT relies on speciﬁc avail-
ability of paralogous dispersed repeats and requires
speciﬁc paralogous sequence-dependent assay design.
Array CGH, SNP arrays and CNV arrays with redun-
dancy of probes for CNV regions achieve some reason-
able accuracy through the effectively replicate reads from
multiple syntenic probes (9–11). These arrays are excel-
lent for initial scans (assuming target representation)
along the lines of SNP GWAS (12), but are unsuitable
for targeted larger scale follow-up studies. The same will
be true for next-generation sequencing, which also
favours, at its cost, high-density data on a smaller
number of individuals (13).
Quantitative ratiometry using four different primers
(one for each end of the target and reference amplicons)
is compromised by differences in binding and priming
efﬁciencies of each primer. Other factors such as consist-
ency of DNA quality, difference in amplicon size and
residual protein contamination can further distort ratios
(14). The independence of the amplicons also means that
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will catch up on or even overtake its counterpart in the
reaction duplex until strand re-annealing relative to
primer depletion slows the respective ampliﬁcation. We
set out to minimize the limitations of ratiometry due to
differences in priming and ampliﬁcation kinetics by using
a single universal primer to amplify both target and refer-
ence amplicons after a preliminary sequence-speciﬁc initi-
ation, and by minimizing differences in amplicon size as
far as possible. Similarity of amplicon size ensures that
signal strength, dependent upon the amount of ﬂuorescent
dye bound by the double strand, is comparable for each
amplicon.
Ampliﬁcation ratio control system
A principle underlying our ‘ampliﬁcation ratio control
system’ (ARCS) is that DNA is ampliﬁed during the
ﬁrst (linear) phase using four different primers (one for
each end of target and reference amplicons), each consist-
ing of an identical universal 50 sequence and a unique
template-speciﬁc 30 sequence. During the second (expo-
nential) phase, ampliﬁcation is driven by the single univer-
sal primer ensuring that the kinetics of ampliﬁcation for
target and reference are as uniform as possible.
Accordingly, the ﬁrst two priming cycles are performed
using a low annealing temperature during which the 30
(sequence-speciﬁc) ends of the composite universal/
sequence-speciﬁc primers anneal to the template; two is
the minimum number of cycles required to deﬁne the
ends of the two strands of each amplicon (although
three cycles are required to generate the ﬁrst duplex mol-
ecules bounded by primer sequence at both ends).
Thereafter, the annealing temperature is raised substan-
tially, whereupon the sequence-speciﬁc primers cannot
prime and ampliﬁcation is driven solely by the single uni-
versal primer, which primes both ends of all fragments.
An important point in the idea to use a single universal
primer (UP), is that this UP favours the intra-molecular
formation of a stem and loop structure by single-stranded
DNA during the cooling phase between melting and an-
nealing of the PCR cycle, as the bases comprising the uni-
versal sequence at one end of the strand anneal to their
complements at the other, to form a stem (Figure 1). This
provides a uniform (or ‘chaperoning’) annealing and amp-
liﬁcation environment, thus minimizing differences in
ampliﬁcation kinetics between fragments and helping to
preserve accurate ratiometry. While counterintuitive, in
that one might expect the stem structure to prevent
priming [e.g. suppression of PCR by the formation of
‘panhandle’ structures (15)], we show that there are
critical features necessary in ARCS design in order to
allow the UP to invade the stem structure (16) and
prime synthesis.
In the embodiment of ARCS described here, we distin-
guished test and reference amplicons in liquid phase by
their %(G+C) content, testing CNV of the haptoglobin
gene (HP) duplicon and the chemokine (C-C motif) ligand
3-like 1 gene (CCL3L1) as proof of principle. The ratio of
target gene product to reference gene product was
measured with an end point liquid phase melting curve
analysis instrument with melt status marked by a
backbone binding dye ﬂuorescent in the presence of
duplex DNA. Overall, the combination of features we
present enables a high-throughput quantitative method
for CNV analysis in an ‘end point’ PCR format, with
low reagent costs using a reaction design which is generic
and applicable to any CNV. As well as summarizing
existing methods for CNV assays, Supplementary
Table S1 also compares the characteristics of ARCS to
these other methods.
MATERIALS AND METHODS
The design of ARCS hinges on the conjunction of the
following principles:
(1) To apply ratiometry between test and reference
amplicons as the means of CNV quantitation.
Figure 1. Possible single-stranded structures. (a) Universal primer
sequence at 50-end of fragment forming hairpin with its distal reverse
complement, (b) Universal primer annealed to its target and
(c) Predicted intermediate stage of primer invasion of ‘stem’ structure.
e54 Nucleic Acids Research, 2011,Vol. 39,No. 8 PAGE 2 OF 12(2) To ‘lock’ the ratio of test and reference amplicons
during the duplex reaction by ensuring that exponen-
tial phase reaction depends only on ‘universal’
priming which is identical between amplicons, and
not on their sequence-speciﬁc primers.
(3) To ‘chaperone’ 30-ends of strands and create a single
universal primer target by engineering a single uni-
versal priming of all strands by the same primer. The
consequence is that single strands will all form
hairpins involving the UP target and its reverse com-
plement sequence at the opposite end of the strand
(this does not preclude primer invasion—see ‘Results’
section). Hairpin formation should also serve to
delay re-annealing of the complementary strands in
later cycles, sustaining representation of the molar
ratio of PCR targets in the original template, over
a greater number of cycles.
(4) For economical and convenient liquid phase read of
reactions, the reference was chosen to have different
%(G+C) content from the test, such that melting
could discriminate amplicons. Quantity was
determined by change of ﬂuorescence of a dsDNA
backbone binding dye.
Amplicon composition and primer design
Due to the necessary %(G+C) difference between target
and reference amplicons, these were designed to be as
short as possible to minimize differences in ampliﬁcation
kinetics. The use of short amplicons also minimized
length-dependent differential ampliﬁcation. The ARCS
hairpin may itself serve to reduce other sequence-
dependent internal conformation.
We chose to discriminate amplicons in duplex reactions
by selecting a reference genomic target containing differ-
ent %(G+C) content compared with the test genomic
target although amplicons were of similar length.The dif-
ferential melting of these amplicons enabled amplicon dis-
crimination in liquid phase, quantitatively monitored
post-PCR by ﬂuorescence change of the binding dye
‘EvaGreen’ during thermal ramping in a LightTyper
(Roche Diagnostics Corporation, Indianapolis, Indiana,
USA).
The initial conﬁguration of the ARCS assay, developed
to measure the limited CNV range of the HP duplicon
(0, 1 or 2 copies of duplicon junction per individual),
utilized three initial low-temperature (49 C) cycles for an-
nealing of the target-speciﬁc primers, followed by  30
high temperature (67 C) cycles to restrict annealing, and
thus priming of all amplicon ends, to the UP. While this
gave adequate discrimination for the HP duplicon CNV, it
became apparent that the greater resolution required for
CCL3L1 CNV could be provided by increasing the length
of the UP to raise its annealing temperature (to 70 C) to
maximize the annealing temperature difference between
target-speciﬁc primers and UP, and by reducing the
number of low-temperature cycles from three to two
while increasing the duration of these steps to allow the
target-speciﬁc primers ample time to saturate all available
priming targets. Two cycles is the minimum number
required to deﬁne the ends of the amplicons without
entering exponential phase using template-speciﬁc
primers with differing priming efﬁciencies.
In order to ensure faithful representation of template
test to reference amplicon ratio through the ARCS
PCR, the following criteria for design of primers and
amplicons should be met:
(i) Template-speciﬁc primers: one or more ‘A’s or ‘T’s
at the 30-end to minimize the possibility of priming
at the higher, UP speciﬁc, annealing temperature.
Contrast with CGG at 30-end of UP, to maximize
priming at the higher temperature.
(ii) Maximize annealing temperature difference between
universal and target/reference primers, and thus
minimize high temperature (cycle three onwards)
mispriming by the template-speciﬁc primers.
(iii) Ample annealing and extension time (e.g. 5min
each per cycle) should be provided for
target-speciﬁc primers during the ﬁrst two, critical,
cycles.
(iv) Sequence-speciﬁc primers: %(G+C) content as low
as possible to mimimize annealing temperature,
while still high enough to prevent low-temperature
mispriming.
(v) Target and reference amplicons: the number of
bases between the priming sites should be
minimized (the shorter the amplicon, the lower
the probability of other molecular interactions),
while still containing sufﬁcient %(A+T) or
%(C+G) (e.g. 150–200bp total) to achieve an ap-
propriate melting domain suitable for melt-based
quantitation (this would not be necessary if a
reaction readout were to be by a method other
than melt analysis).
(vi) Target and reference amplicons: approximately
same length if possible.
(vii) Speciﬁc attention must be paid to the bases imme-
diately distal to the cognate target for the UP. This
is crucial, but can be accounted for in the generic
design of the composite UP-sequence-speciﬁc
primers (See ‘Results’ section).
For proof of principle, we used two genes representing
copy number variant sequences: HP (0, 1 or 2 copies of
a tandem duplication junction) (17) and CCL3L1
(0–6 gene copies in the European population, 2–16 in
African populations) (18). For HP, we ampliﬁed across
the junction of the tandem duplication, choosing a low
%(G+C) amplicon [146 bp including universal sequence
ends, 48.28 %(G+C)]. For CCL3L1, we chose a low
%(G+C) amplicon [179 bp including universal sequence
ends, 46.93 %(G+C)]. The reference fragment in each case
was a relatively high %(G+C) amplicon from the
single-copy TP53 gene [136 bp, 57.35 %(G+C)].
PCR ampliﬁcation (HP)
The 1.5ml droplets containing 15ng of DNA were dried
for 5min at 80 C in the wells of skirted white 384-well
microplates (Greiner Bio-One). Primer sequences are
listed in Supplementary Table S2. PCR mix contained
the following sequence-speciﬁc primer concentrations,
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minimize peak height measurement error: HP forward
and HP reverse 0.3mM, TP53 forward and TP53 reverse
0.2mM. The remaining PCR mix contained: 1.04M
betaine, 1.5  (ﬁnal concentration) buffer per 5ml
reaction (‘Go-Taq Flexi buffer 5  concentrate’.
Promega, Madison, WI, USA), 2.5mM MgCl2,U Pa t
1.0mM, deoxynucleoside triphosphates (dNTPs) at
200mM each, 0.25U of ‘Go-Taq Flexi’ polymerase
(Promega) per 5ml reaction, EvaGreen ﬂuorescent dye
(Insight Biotechnology) at a ﬁnal concentration of 0.2 
per 5ml reaction, and 0.7ml water (to 5ml total volume) per
microplate well. Thermal cycling parameters were as
follows: 94 C 2min; three cycles (for the sequence-speciﬁc
primers) of: 94 C 1min, 49 C 1min, 72 C 1min; 28 cycles
(for UP) of: 94 C3 0 s ,6 7  C3 0 s ,7 2  C3 0 s ;7 2  C 2min.
Subsequent experience has shown that two initial cycles,
instead of three, is optimum, together with 5min each
annealing and extension for these two cycles.
Ampliﬁcation was performed using a DNA Engine
Tetrad2 (MJ Research Inc, Waltham, Massachusetts,
USA).
PCR ampliﬁcation (CCL3L1)
The 1.5ml droplets containing 15ng of DNA were dried
for 5min at 80 C in the wells of skirted white 384-well
microplates (Greiner Bio-One). Primer sequences are
listed in Supplementary Table S2. PCR mix contained
the following: CCL3L1 F&R 0.25mM, TP53 F&R
0.25mM, 1.04M betaine, 1.5  (ﬁnal concentration)
buffer per 5ml reaction (‘Go-Taq Flexi buffer 5  concen-
trate’. Promega, Madison, WI, USA), 2.5mM MgCl2,
‘improved UP’ at 1.0mM, dNTPs at 200mM each, 0.25
U of ‘Go-Taq Flexi’ polymerase (Promega) per 5ml
reaction, EvaGreen ﬂuorescent dye (Insight
Biotechnology) at a ﬁnal concentration of 0.2  per 5ml
reaction, and 0.7ml water (to 5ml total volume) per
microplate well. Thermal cycling parameters were as
follows: 94 C 2min; two cycles of 94 C 1min, 49 C
10min, 72 C 5min; one cycle of 94 C 1min, 64.5 C
5min, 72 C 5min; 30 cycles of 94 C3 0 s ,7 0  C3 0 s ,
72 C3 0s ;7 2  C 2min. The CCL3L1 ARCS methodology
differed slightly from that used for HP for the reasons
already explained. The longer UP (‘improved UP’) used
for CCL3L1 was made by adding four bases to the
existing UP 50-end. However, since the composite target
and reference primers were unchanged, an intermediate
(64.5 C) step was included between low and high tem-
peratures annealing to accommodate the transition
involving the four base 50 overhang of the improved UP.
This is now used by our laboratory as the default for
ARCS ampliﬁcation. Since the development of the assay
we have reduced the amount of DNA used to 10ng per
reaction.
After ampliﬁcation, formamide was added to each well
at a ﬁnal concentration of 20% v/v to lower amplicon
melting temperatures to a range suitable for the melting
curve instrument used. To each well, 7ml of Chillout 14
TM
liquid wax (MJ Research) was added, and the microplate
was centrifuged at 3000rpm for 3min before being
analysed in a 384-well LightTyper. The melt ﬁle was
analysed by Perl software written in-house, which calcu-
lates peak heights (as proxy for areas under the curves)
after subtracting a baseline correction; it then generates
cluster plots (reference peak height versus target peak
height, and reference/target ratio versus total yield) and
outputs peak height ratios in spreadsheet format, for
further analysis. Samples with a 45 C ﬂuorescence
reading below a default or user-deﬁned threshold are
excluded from further analysis as low ﬂuorescence
readings are more prone to measurement error. Nulls
are handled separately with absence of a target gene
peak being output as zero. The software is available on
request.
ARCS/sequence-speciﬁc PCR ratio consistency over
PCR cycles
The ratiometric robustness of ARCS over cycle number
was assessed by performing an HP copy number assay
with and without ARCS. We designed target and reference
primers which were identical to those used in ARCS, but
which had been extended 50 to increase their annealing
temperature to a value more representative of typical
PCR (e.g. 55 C—see Supplementary Table S2 for
sequences).
Application (The British women’s heart & health study
cohort)
We used ARCS to perform a genotyping assay for the HP
duplicon CNV in the British Women’s Heart and Health
Study cohort (BWHHS—4286 women selected randomly
from 23 British towns, aged between 60 and 79 years at
enrolment, between 1999 and 2001) for whom DNA was
available for 3271 (19). A total of 2914 samples from the
cohort were genotyped by ARCS for HP copy number,
giving the genotype frequencies shown in Supplementary
Table S3.
CCL3L1 real time PCR
The DNA samples analysed for CCL3L1 CNV by ARCS
were also analysed by real time PCR to verify the perform-
ance of ARCS, using a Roche LC480 Light Cycler. The
2.0ml droplets of DNA (20ng) were dried for 8min at
80 C as above. Primer sequences are listed at the end of
Supplementary Table S2. The PCR mix contained 1.04M
Betaine, 1.5  (ﬁnal concentration) buffer, 2.5mM MgCl2,
primers at 2.5mM, dNTPs at 200mM each, 0.5U of Taq
polymerase, EvaGreen ﬂuorescent dye at a ﬁnal concen-
tration of 0.2  and water to 10ml per microplate well.
Thermal cycling parameters in the LightCycler were as
follows: 94 C 2min; 50 cycles of 94 C2 0s ,5 5  C3 0s ,7 2  C
30s. Ampliﬁcation was performed in white Light Cycler
96-well skirted plates. Relative quantitation, calibrated
against standard curves generated for the CCL3L1 and
TP53 amplicons (at two copies each), was performed
using two replicates for CCL3L1 and two for TP53 for
each DNA sample. DNA samples giving anomalous
(outlier) results were re-ampliﬁed using four replicates
each for CCL3L1 and for TP53. CCL3L1/TP53 ratios
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generated by ARCS.
The ‘A’ set of DNAs used to generate data for
Supplementary Figure S1 was extracted from EDTA
blood obtained from National Health Service Blood and
Transplant in Filton, UK. The extraction was performed
in 2010 in the Bristol Genetic Epidemiology Laboratory,
School of Social and Community Medicine, University
of Bristol, UK, using a kit (‘DNAquik’ BioServe
Biotechnologies, Beltsville, MD, USA) based on a
salting-out protocol. The DNA was quantiﬁed using
NanoDrop (Thermo Scientiﬁc, Wilmington, DE, USA)
and standardized to 10ng/ml. The ‘B’ set was extracted
from EDTA blood used for a study on intracranial
aneurysm (Polymorphism in matrix metalloproteinase-1,
-3, -9 and -12 genes in relation to subarachnoid hemor-
rhage. Stroke 2001;32:2198–202). The extraction was per-
formed in 1999 in the Human Genetics Research Division,
School of Medicine, University of Southampton, UK,
using an in-house salting-out protocol. The DNA was
quantiﬁed by ﬂuorimetry using PicoGreen (Invitrogen
Ltd, Paisley, UK), and standardized to10 ng/ml.
The program used to generate Supplementary Table S4
was written in Python, and is listed in Supplementary
Note 1.
RESULTS
To test the effect of base pairing immediately down-
stream of the UP on the efﬁciency of ampliﬁcation, we
designed a set of primers for the reference (TP53)
amplicon (see Supplementary Table S2 for primer se-
quences) that would result in various combinations of
base pairing at this position (Figure 2). The peaks in this
ﬁgure demonstrate that base pairing at the ﬁrst position
downstream of the UP is critical in affecting ampliﬁca-
tion efﬁciency. If the ﬁrst position is not base paired,
pairing at positions 2, 3 or both appears to exert
moderate effects. If, however, the ﬁrst position is base
paired, additional pairing immediately downstream can
be seen to further inhibit ampliﬁcation progressively,
with ampliﬁcation almost entirely blocked when all three
bases are paired.
To further investigate obstruction of oligonucleotide
invasion by the UP (16), and/or blocking of extension
by Taq polymerase from the bound UP, we designed a
new experimental pair of primers for the reference
(TP53) amplicon. These consisted of the target-speciﬁc
sequences previously used for the ﬁrst two ampliﬁcation
cycles but with the addition of a 19-base complementary
sequence between the UP and target-speciﬁc sequences,
such that the UP stem would be extended upon
fold-back to form an unbroken stem of 45 paired bases
(see last two sequences in Supplementary Table S5). The
comparison for ampliﬁcation over 35 cycles, primed for
the ﬁrst two cycles either by ordinary or by ‘zipped up’
primers is shown in Figure 3, where ampliﬁcation using
the ‘zipped-up’ primers can be seen to have been totally
inhibited.
Haptoglobin duplicon CNV: an ARCS assay combined
with melt curve analysis
Supplementary Figure S2 shows the intra-gene context for
the HP and TP53 (reference) amplicons. The melting
curves of duplex PCRs for the amplicon bridging the
HP gene duplicon junction and single copy gene TP53
amplicons are presented in Figure 4. These demonstrate
the effect of selecting amplicons with %(G+C) differing by
 9% to give ﬁrst derivative curve peak separation of
 4 C. Hp 1,1 (single copy on both alleles, so null for
duplicon junction) is represented here by an absence of
the left-hand (HP) peak (panel ‘a’), whereas panels ‘b’
and ‘c’, respectively, display one (Hp1,2) or two (Hp2,2)
copies of the duplicon junction. Sample output from peak
height measuring software developed in-house is shown in
panel ‘d’. Two representations of clustering for CNV
genotype calls are shown in the upper and lower parts of
panel ‘a’ of Figure 5. There are three groups of ﬂuores-
cence signal strength for HP relative to TP53, representing
0, 1 or 2 copies of HP duplicon. Copy number genotype
totals in the discrete clusters were consistent with Hardy–
Weinberg equilibrium for a total of 2914 unrelated women
in BWHHS—a cohort of older British women (19)
(Supplementary Table S3); CNV genotyping was per-
formed for 3271 DNA samples with 11% of calls being
discarded due to low yield PCR.
CCL3L1 CNV
In panel ‘b’ of Figure 5, the upper plot showing reference
TP53 peak height versus CCL3L1 peak height shows three
major classes radiating from the origin, corresponding to
1, 2 and 3 copies of CCL3L1 per diploid individual. The
lower plot of CCL3L1/TP53 ratio (‘x’ axis) and yield
(‘y’ axis) shows main clusters corresponding to 1, 2 and
3 copies, respectively, from left to right.
The CCL3L1/TP53 ratio data generated in the form of
5-fold replicates for 96 samples, for the purpose of
estimating consistency (see under ‘Error frequencies’ in
‘Results’ section), were also plotted in two forms:
Supplementary Figure S3 shows plots of ratio and yield,
with and without correction for yield-associated skewing,
demonstrating that ratio intervals for averages of repli-
cates are close to those predicted (intervals of  0.5);
Supplementary Figure S4 shows the clustering evident
when plotting ratios from one of a pair of replicates
against the other.
ARCS versus sequence-speciﬁc priming
In Figure 6, distinct clustering for the HP duplicon assay
has been lost for standard sequence-speciﬁc duplex PCR
at 36 cycles, whereas the clusters remain sharply deﬁned
in the equivalent ARCS assay. Regression of CCL3L1/
TP53 ratios obtained for 33 cycles against 53 cycles, for
ARCS and for sequence-speciﬁc PCR (Supplementary
Figure S5), showed that approximate rank order of
ratios was being maintained for ARCS but not for
sequence-speciﬁc priming.
PAGE 5 OF 12 Nucleic AcidsResearch, 2011, Vol.39,No. 8 e54Figure 2. Effects on ampliﬁcation of base pairing distal to the UP stem. (a) Three bases, all pairing. (b) Three bases with no base pairing.
(c) Designation of important base positions relative to the UP ‘stem’ (+1, +2 or +3). (d) Panels show effects of match or mismatch at positions
+1, +2, +3. Left peak in panels is CCL3L1 amplicon, right peak is reference TP53. Numbers denote position of bases paired downstream of
universal primer (‘0’ in top panel indicates no base pairing). Using the same template DNA, positions +1 to+3 were varied in the TP53 amplicon.
Note that a single-matched pair of bases at position 1 severely inhibits ampliﬁcation of the TP53 amplicon, and pairing of all three bases effectively
blocks ampliﬁcation altogether. Reference peak heights as fraction of reference peak in panel 0 where none of positions +1 to +3 was base paired:
1)0.17 2)0.84 3)1.05 1,2)0.07 1,3)0.25 2,3)0.71 1,2,3) negligible.
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We quantiﬁed the CCL3L1 copy number polymorphism
in 24 DNA samples by ARCS and by real time
sequence-speciﬁc PCR (Roche LC480). A regression of
CCL3L1/TP53 ratios for real time PCR to ARCS
(Supplementary Figure S6) gave a high value for correl-
ation (Pearson correlation coefﬁcient=0.910, R
2 0.83,
r=4.47 10
 9), indicating that ARCS end point PCR
is effective as a quantitative technique. A grid of cluster-
based copy number calling for each sample, by ARCS and
by real-time PCR (Supplementary Table S6), for those
samples assayed in Supplementary Figure S6 shows
perfect agreement. To investigate the relative performance
of ARCS versus real time PCR (Roche LC480) for DNAs
of differing origin, we analysed CCL3L1 copy number for
two different sets of 45 DNAs, each of which was ex-
tracted and quantiﬁed by different people using different
protocols, in different laboratories. The plots in
Supplementary Figure S1 show that ARCS was able to
successfully cluster CNV classes in both cases, and that
ARCS performed better than real time PCR for the DNA
‘A’ set.
ARCS consistency
In Supplementary Figure S7, a regression of CCL3L1/
TP53 ratios obtained from one 53 cycle ARCS run
against another showed that at high cycle number,
approximate rank order of ratios was being maintained.
Large-scale run
For HP duplicon CNV, using 384-well microplates, we
were able to process all samples in a cohort DNA bank
(in one batch, 12 384-well microplates, at under 2h per
PCR, plus 15min per LightTyper run). Sample output is
shown in Figure 5, panel ‘a’, where ARCS can be seen to
give three distinct groups, representing 0, 1 or 2 copies of
the duplicon junction per diploid genome. Final data and
Hardy–Weinberg equilibrium test are given in
Supplementary Table S3.
Error frequencies
A total of 96 DNA samples were genotyped for HP and
CCL3L1 CNV, a total of 5 for each gene. Standard
deviations were as follows:
Hp1,1: N/A (no ratio data—only reference peak present);
Hp1,2: SD 0.05 (n=246); Hp2,2: SD 0.059 (n=152)
CCL3L1: 1 copy: SD 0.107 (n=88); 2 copies: SD 0.190
(n=223); 3 copies: SD 0.245 (n=73); 4 copies: SD
0.371 (n=29).
DISCUSSION
We present a new approach to CNV quantitation. This
approach, ARCS (ampliﬁcation ratio control system),
Figure 4. LightTyper reads from ARCS duplex PCR of HP duplicon
and TP53 reference amplicon. (a–c) 0, 1 or 2 copies of the HP duplicon
junction (left peak); right peak represents TP53 reference amplicon.
(d) Sample of output from software developed in-house, with
automatically-generated baseline and positions of maximum peak
heights. x-axis, temperature; y-axis, negative ﬁrst derivative of the ﬂuor-
escence trace.
Figure 3. Effect on ampliﬁcation of extensive sequence homology
between UP stem and target-speciﬁc sequence. (a) First derivative ﬂuor-
escence peak of TP53 amplicon with no homology immediately beyond
UP stem. (b) Fluorescence peak for same amplicon with base pairing
for 19 bases beyond UP stem.
PAGE 7 OF 12 Nucleic AcidsResearch, 2011, Vol.39,No. 8 e54Figure 5. Raw data plots of microplate assays. (a) ARCS assay for HP duplicon junction CNV (85 data points) and (b) CCL3L1 CNV (94 data
points). The top panel for each consists of reference peak (TP53) height plotted on the x-axis against CNV gene peak height on the y-axis. The lower
panel for each consists of the ratio of CNV gene peak height/TP53 peak height plotted on the x-axis against ﬂuorescence intensity on the y-axis.
Each point plotted in the CCL3L1 panels represents an arithmetic mean of duplicate assays. Note that null allele clusters lie directly on the x- and
y-axes for the respective plots.
Figure 6. Haptoglobin duplicon junction assay using either sequence speciﬁc or ARCS-PCR. Hp1,1—no duplication alleles; Hp1,2—1 duplication
allele; Hp2,2—2 duplication alleles. Top part of each panel: TP53 reference peak height (x-axis), Hp duplicon junction peak height (y-axis). Lower
part: HP/TP53 peak height ratio (x-axis), ﬂuorescence intensity (y-axis), corrected for skewing with yield. There is no clustering for standard
sequence-speciﬁc PCR at 36 cycles, whereas in the ARCS assay (85 data points), genotype groups remain well resolved.
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Principles of ARCS at the beginning of the ‘Materials
and Methods’ section) of annealing, priming and melting
such that ratio of test and reference amplicons is repre-
sented to near plateau phases (e.g. 35 cycles) PCR, and
rank of ratios remains well preserved even through 20
further cycles in plateau phase. By avoiding real time
PCR, the throughput is limited only by (end point) PCR
capacity. Ratios are read in liquid phase directly from the
end point PCRs. Except for unlabelled sequence-speciﬁc
initiating primers, all reagents are generic. The design is
generic for copy numbers lower than four, and therefore
an assay for any new low copy number target is readily set
up. Differentiation of clusters of four copies and above, as
their separation progressively decreases, is beyond the
scope of the current rendering of ARCS, although it
remains valid for the approximate quantitation of higher
copy number. By plotting the CNV genotype of a large
enough number of individuals, actual copy number can be
determined through clustering (for example, the clusters
for 0,1 and 2 copies being quite distinct and with central
means that can be determined) without recourse to known
positive controls. Prior knowledge of the proportions
expected within each cluster can be obtained from the lit-
erature and used to anchor new data, and additional sup-
porting information on expected allelic composition of the
CNV classes can be obtained from re-analysis of existing
data using expectation maximization programs such as
CoNVEM (20). The ARCS approach has signiﬁcant ad-
vantages over real time PCR in the large-scale genetic epi-
demiological follow up of CNVs in banks representing
tens of thousands of study participants. In order to run,
for example, eight plates in parallel for large-scale studies
using real time PCR, eight real time PCR machines would
be required. These each incur a major capital cost being a
combined cycler and ﬂuorescence reader which is inher-
ently complex. In contrast, uncoupling the reaction and
the read and being able to use an ‘end point’ reaction,
allows eight plates to be cycled on two 4-block PCR
cyclers, then read for 10–15min each on a LightTyper
plate reader. The capital cost of this equipment in total
is comparable with the cost of one real-time machine.
ARCS should also be applicable in other quantitative
PCR applications.
In this study, we sought to develop an approach for
CNV quantitation suitable for population studies and
also with potential for larger multiplex ampliﬁcations
compatible with diagnostic needs, chip technologies and
next-generation sequencing. Fundamental objectives were
that the approach should maintain an accurate precise
representation of the molar ratio of targets in the
original template DNA; that the approach should be
generic for CNVs; that the approach should be simple to
set up; that the approach should be economical with
respect to reagents, hardware needs and staff time; that
the assay could be read in liquid phase without the need
for real time PCR; and, crucially, that the approach would
be capable of population scale follow-up studies of speciﬁc
CNVs. ARCS capitalizes on a design which causes
synthesized single strands to form a hairpin which ‘chap-
erones’ the single universal priming site and 30-ends of
synthesized strands. In the format for reading reactions
described herein, liquid phase readings are enabled by dif-
ferentiation of the short amplicon products (test and ref-
erence) through different %(G+C) content and hence
differential thermal melting and dye-bound ﬂuorescence
change in the non-hairpinned segment (‘ARC’) when it
is represented in its duplex DNA form (although we
note that, as the ARCS assay does not depend on the
melting method, in the future other conﬁgurations for ob-
taining read out will also be possible). The other desired
characteristics follow from this general design.
The underlying feature of the method is the use of a
single universal primer to prime both ends of all ampl-
icons, after the initial two target-speciﬁc cycles, and thus
maximize the uniformity of ampliﬁcation conditions. We
initially experimented with 10, 9, 6, 5, 3 and 2 target-
speciﬁc cycles and found that the best outcome was
obtained by using the lowest number. This is consistent
with what one would predict, i.e. that slight differential
priming efﬁciencies for speciﬁc primers will be exponen-
tially more problematic the higher their cycle number. We
showed that intra-molecular hairpin formation does, as
predicted, take place and identiﬁed a number of important
features of that in relation to the ARCS reaction, most
important of which is the identical priming environment
created for target and reference amplicons. ARCS strands
denatured by the 96 C step of PCR can undergo three
possible events. First, they can re-anneal to form perfect
duplexes in which case priming (off such dsDNA) would
not be expected. Second, they may immediately form a
hairpin as the temperature is lowered. We showed that
this event predominates in early cycles, since ampliﬁcation
is either much reduced (if bases +1 to +3), or totally in-
hibited (if bases+1 to+19) beyond the UP form base pairs
with their opposites at the UP0 end, for one of the pair of
amplicons in a duplex PCR. This raises the question of
how priming can take place given the intra-molecular UP
‘stem’ (Figure 1). However, our data indicate that this
mechanism operates effectively during ARCS reactions.
Gasanova et al. (16) demonstrated that invasion of a
duplex by an oligonucleotide complementary to one of
the ends can proceed via displacement. In the design of
ARCS primers, we ensure mismatches in the intra-strand
panhandle at +1 to +3 relative to the universal primer
sequence, whereas in a standard PCR in its late cycles,
when strands re-anneal before new oligo priming, +1 to
+3 will be base paired inter-strand. The somewhat lower
efﬁciency per cycle but greater plateau yield of ARCS
compared with sequence-speciﬁc PCR are consistent
with this (see Supplementary Figure S8). Third, immedi-
ately after denaturation, single strands may hybridize with
a UP molecule for a priming event. We calculate
(Supplementary Note 2) that amplimer strand opposite
ends are likely to be 5- to 10-fold closer in all three
spatial dimensions (to form a UP ‘stem’) than the 30-end
would be to a UP molecule. Thus, hairpin formation is
much more likely than immediate UP priming, despite the
relatively high molarity of UP at the start of an ARCS
PCR. Our data conﬁrm this, in that base pairing in the
single-stranded template molecule immediately down-
stream of the 30-end of the universal primer would limit
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and initiate priming. We have shown that this does depend
on the amount of base pairing distal to the UP ‘stem’,
which shows that hairpin formation does take place fol-
lowing PCR denaturation steps. Since base pairing distal
to the UP ‘stem’ can completely prevent ampliﬁcation,
even after 50 cycles, it implies that hairpin formation
must be the predominant event (compared with UP an-
nealing) in early cycles. It must also be generally true that
any UP incorporation into a single strand will be
accompanied by both a depletion of the UP and a synthe-
sis of a reverse complement of UP in the strand,
perpetuating the predominance of hairpin formation
until the sole UP depletes and hairpin formation can
only be followed by rearrangement to the double strand
amplicons.
As a result of experimenting with two universal primers
(one forward, one reverse), it was found that ampliﬁcation
of the target and reference sequences was either negligible
or very poor due to the preferential formation of short
( 80–90bp) primer dimer ampliﬁcation products. We
were unable to eliminate this problem, and conclude that
the combination of low annealing temperature necessary
for the temperature segregation of the phases of the PCR
and used for the target-deﬁning ﬁrst two cycles, combined
with long annealing time to ensure quantitative priming,
provides a conducive environment for the formation of
primer dimers between the sequence-speciﬁc parts of the
various oligos if one uses different forward and reverse
universal primers—in contrast, ARCS prevents these
events. The most plausible explanation is that whereas
the bases immediately downstream of the UP sequence
in the UP/target-speciﬁc composite primer pairs are delib-
erately mismatched to avoid base pairing and thus ensure
ampliﬁcation, any ‘unforeseen’ base pairing immediately
downstream of the 50 UP sequence in a hairpinning primer
dimer strand will inhibit ampliﬁcation. Compared with the
use of more than one universal primer, use of a single
universal primer has several additional advantages. First,
a major advantage is that using a single universal primer
provides the opportunity of shutting down the risk of
cross-pair primer dimering mentioned above by judicious
choice of the+1+2 bases downstream of the 30-end of the
universal sequence (Figure 2), to maximize opportunities
for +1 and/or +2 base pairing of single-stranded
hairpinning primer dimer products; see Supplementary
Table S4 for a list of optimum choices of +1+2 bases to
ensure ampliﬁcation of desired product and suppression of
potential primer dimers. Second, the amplicon melting
proﬁle is more uniform that it would otherwise be, since
both ends will behave the same. Third, there is somewhat
less risk of primer dimer formation, since there are fewer
primer 30-ends and high molarity oligo sequence combin-
ations at risk of dimerization. Finally, planning of
amplicons is simpliﬁed and costs of oligo purchasing are
reduced.
The reference amplicon can be designed to be either
%(G+C) rich or %(G+C) poor, depending upon
%(G+C) status of the target amplicon, from which they
will be resolved by melt analysis. This approach, using
quantitation by a ﬂuorescent binding dye, is generic and
applicable to any target amplicon.
We appreciate that having target and reference
amplicons that differ in their %(G+C) content risks an
effect on ampliﬁcation efﬁciencies, but such effects are
reduced by (i) the use of short amplicons to reduce the
opportunity for secondary structure to form, (ii) the
ARCS hairpin which should help to suppress other
sequence-dependent secondary structure and (iii) the use
of Betaine. The use of target/reference ratios derived from
one-dimensional peak heights as opposed to
two-dimensional peak areas may currently limit the
accuracy of measurements; however, other resolution
and detection methods such as ﬂuorescence capillary elec-
trophoresis of multiplexes or multiplex hybridizations
should be equally compatible with ARCS. For genes
such as CCL3L1 (data shown), and AMY1, CYP2D6
and DEFB4 (data not shown), the assay is quantitative
but precise boundaries between higher size classes (e.g. 4
versus 5) are less apparent and therefore cannot be directly
enumerated as fully resolved clusters of points in a plot
such as in Figure 5, panel ‘b’. In this situation, calibration
can either be by standards already quantiﬁed by a direct
technique such as ﬁbre FISH, or by standards consisting
of artiﬁcial target and reference fragment pairs assigned
by differing ratios to deﬁned microplate wells. The
primary application for which ARCS was developed was
rapid, large-scale CNV typing in genetic epidemiological
studies. The results for an epidemiological trial of the ﬁrst
ARCS assay to be developed (for the HP duplicon, see
Supplementary Table S3) show good agreement with pub-
lished phenotypic data for Hp1 frequencies in British/
European/European-derived study populations (21–23)
(ARCS Hp1=0.36 cf 0.39/0.40/0.39, respectively); a 
2
contingency test showed no statistical differences
(r=0.99992) among the allele frequencies of the four
populations.
ARCS-generated CCL3L1 copy number for the ARCS/
real time PCR comparison was obtained at 33 cycles, cor-
responding to 30 cycles (because no ﬂuorescence was read
for the ﬁrst three cycles) in the plot of real time PCR
performed using sequence-speciﬁc primers
(Supplementary Figure S6). This is the point at which
ampliﬁcation is reaching plateau, and at which ARCS
gives good agreement with (sequence-speciﬁc) real time
PCR i.e. ARCS ratios measured at this cycle number are
accurate as well as precise. However, even after a further
20 cycles in plateau phase, measured ratio still correlated
well between runs (Supplementary Figure S7) and with
data from 33 cycles (Supplementary Figure S5) although
there is a degree of ‘catchup’ by the reference amplicon.
We surmise that the slow ‘catchup’ by one amplicon
relative to another, once the reaction is in plateau phase,
represents differential re-annealing of the short speciﬁc
sequence loops used in the format described here for
amplicon discrimination by %(G+C) content.
Thus ARCS, unlike sequence-speciﬁc PCR, maintains
relative, if not absolute, ratio information far into
plateau phase. In contrast with sequence-speciﬁc PCR,
ARCS provides synchronized entry to plateau phase for
different co-amplicons, which permits ‘end point’ reads
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the proﬁle of real time PCR using ARCS in the upper
panel of Supplementary Figure S8 shows an apparently
greater yield for approximately three cycles at entry to
plateau phase, unlike sequence-speciﬁc PCR; we hypothe-
size that this represents maximal production of duplexes
and hence maximal double-stranded dye binding, followed
in successive cycles by the formation, by re-annealing (in
contrast with new strand synthesis), of more elaborate
‘Holliday junction’ type structures with less
double-stranded DNA available for dye binding.
We have successfully classiﬁed CCL3L1 copy number in
DNAs derived by different methods in different
laboratories (see Supplementary Figure S1), by both
sequence-speciﬁc real time PCR and by ARCS. It should
be noted that real time PCR required four times as much
DNA as ARCS due to the multiple replicates of target and
reference reactions required for real time. We also note
that ARCS may prove to be more tolerant of variations
in DNA quality/quantity than real time PCR; the full
breadth of any such tolerance will need to be the subject
of a separate study.
We compare the characteristics of ARCS with other
CNV typing methods in Supplementary Table S1. A com-
parison of ARCS with real time PCR has conﬁrmed its
effectiveness as a quantitative technique; although there
was variation in the ranking of individual ratios between
ARCS and real time PCR (groups of which should be
identical for any given copy number genotype), there
was total agreement between the two methods in assigning
samples to copy number classes.
The term ‘CNV’ should be interpreted with care, since it
is frequently used to refer to the simple biallelic situation
of deletion or duplication (easily assayed and easily
tagged) rather than the more complex higher order copy
number polymorphisms found in genes such as CCL3L1
or AMY1 (not simple to assay and not tagged in many
cases). Higher order CNVs are likely to be due either to
the high mutational rates of repeating sequence blocks or
to selective pressures, or both. Such mutational rates tend
to uncouple such loci from background SNP haplotypes
(20,24), limiting the potential for SNP tagging. ARCS will
also have particular applicability for the rarer CNVs such
as those implicated in autism and schizophrenia (25,26),
which will not be SNP tagged and which are unlikely to be
easily or accurately imputed from long haplotypes. ARCS
also has potential for clinical applications, typing rare
deleterious duplications (3/2) and deletions (1/2), for
genetic diagnostics, and for being used quantitatively in
the case of cancers, prognosis and treatment response
prediction.
Provided that the design considerations listed in the
‘Materials and Methods’ section are adhered to, ARCS
assays do not generally require any signiﬁcant in vitro op-
timization. The present format, using melting to differen-
tiate test and reference amplicons, requires identiﬁcation
of suitable high and low melting temperature short
segments for test and reference amplicons; we have not
yet encountered an instance where such choice was not
possible.
Potential sources of non-linearity to be considered and
controlled for in the ﬂuorescence detection of the present
assay conﬁguration (unrelated to the ARCS process itself)
are that EvaGreen does exhibit ﬂuorescence with
single-stranded DNA, which would include oligonucleo-
tides (single-stranded DNA ﬂuorescence   one-tenth that
with double-stranded DNA) and exhibits some plateauing
of ﬂuorescence response above DNA concentration of
10ng/ml (27). Furthermore, there is more background
ﬂuorescence decay taking place at lower temperatures,
which will tend to inﬂate the peak height of an amplicon
melting at a lower temperature.
We note that the higher end of the copy number distri-
bution for highly CNV polymorphic genes, e.g. AMY1,
could be assayed using a stably higher copy number ref-
erence gene. We further note that, with adjustments of
format, ARCS has potential for a wide range of other
quantitative applications such as telomere quantitation
(28), methylation quantitation, mRNA qPCR and
protein immunoquantitation when used in conjunction
with immunoPCR. The major advantage in each
instance should be the opportunity to use ‘end point’
PCR for quantitation, allowing the convenience, through-
put and cost reduction available from end point compared
with real time PCR methods.
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